SkinCeuticals has a new general manager in the U.S., WWD has learned.
The L’Oréal-owned professional skin-care brand has named Christina Fair general manager of its U.S. business.
Until last week, Fair served as the vice president of global marketing for SkinCeuticals DMI, the brand’s global division, where she oversaw the development of key strategic products that have quickly achieved cult status, such as Triple Lipid Restore 2:4:2 and HA Intensifier. Fair has been with L’Oréal for 10 years, working in marketing on brands such as Maybelline and Garnier.
Over the past three years at SkinCeuticals, Fair has spearheaded the introduction of medical devices with CryoCorrect, a noninvasive dark spot corrector and skin tag removal tool designed for professional use. She also introduced a personalization technology called Custom Dose, which allows dermatologists to personalize treatment products for patients.
As Millennials drive demand for noninvasive cosmetic procedures and aesthetic treatments at dermatologist offices and medical spas, SkinCeuticals — which is distributed in 33 countries primarily through the medical channel — has experienced brisk growth in the past few years. The brand is also known for its classic antioxidant serums said to neutralize free radical damage, such as CE Ferulic and Phloretin CF, and its post-treatment products like the Phyto Corrective Masque. In 2016, Kline & Co. ranked the brand as number one in the U.S. professional market, and in China the brand grew retail sales 80 percent from 2016 to 2017.
You May Also Like
“We see this rare moment we can capitalize on — you have a market dynamic that is starting to groundswell and a brand that is very strong,” Fair said. Her goal as general manager is to convert the luxury skin-care consumer into a SkinCeuticals consumer, making it a strong contender in the prestige market. Outside of the medical channel, SkinCeuticals is also sold in Bluemercury stores in the U.S. Said Fair, “We know there’s cross-pollination with people who are using high-end skin care.”
Her first initiative will be the launch of Discoloration Defense, a daily serum designed to reduce the appearance of visible discoloration, such as brown spots and post-inflammatory hyperpigmentation. The formula contains 3 percent tranexamic acid — a first for a L’Oréal product — along with kojic acid and niacinimide. This year she’ll also focus on building out the brand’s Advanced Clinical Spas and Aesthetic Centers, where SkinCeuticals partners with a dermatologist or medical aesthetician on exclusive treatment centers, and helps design into the entire client experience.
Fair ultimately sees opportunity for the brand to branch into aesthetic treatments. “We’re looking at where the market is going – women want faster, in-and-out aesthetic procedures, whether it’s superficial peels or low-level lasers, get your home regimen and go,” said Fair. “Our physicians tell us their demographic is getting younger — young women are coming in wanting to prevent, versus 10 years ago when people came in to reverse.”